FDA Drug Application (020067) for EC-NAPROSYN by ATNAHS PHARMA US

Back to FDA Applications sponsored by ATNAHS PHARMA US

Application Number020067
Product Number002
FormTABLET, DELAYED RELEASE;ORAL
Dosage375MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEC-NAPROSYN
Active IngredientNAPROXEN

Active IngredientCount
List of drugs with Active Ingredient NAPROXEN8


Back to FDA Applications sponsored by ATNAHS PHARMA US